T
Tevogen Bio
Clinical-stage specialty immunotherapy company leveraging ExacTcellTM technology platform to harness the power of CD8+ cytotoxic T lymphocytes to develop off-the-shelf, precision T cell therapies for…
About Tevogen Bio
Tevogen Bio is a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T-cell therapies for the treatment of infectious diseases and cancer. The firm's proprietary ExacTcell platform harnesses the power of cytotoxic T lymphocytes (CTLs) to create scalable and rapidly producible treatments.
Read full description
The company's approach focuses on developing therapeutic products that are designed to be accessible and affordable, targeting a broad range of patients. Tevogen Bio is currently advancing its pipeline of product candidates for various viral infections and cancers, leveraging its expertise in cell and gene therapy. As a publicly-traded entity, its business model is centered on the research, clinical development, and eventual commercialization of its immunotherapies.
At a glance
- Status
- Listed
- Founded
- 2020
- Headquarters
- Metuchen, United States
- Listing
- Public via SPAC 2023
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
- SASemper Paratus Acquisition
- POPatel family office
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
3 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Tevogen Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tevogen Bio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.